The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
756
January 1, 1988
View Complete Issue         Table of Contents 2019 
Nabilone And Other Antiemetic For Cancer Patients
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Nabilone And Other Antiemetic For Cancer Patients
January 1, 1988 (Issue: 756)
Nabilone (Cesamet - Lilly), a synthetic cannabinoid chemically related to tetrahydrocannabinol (THC), the main active ingredient in marijuana, was recently marketed in the USA for oral treatment of nausea and vomiting associated with cancer...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Nabilone And Other Antiemetic For Cancer Patients
Article code: 756b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.